People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| JW (Cayman) Therapeutics Co. Ltd | — | Biotechnology | Series D+ | $105.5M | $4.4B | 2020 |
Jingwen Edgar Miao at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jingwen Edgar Miao on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ann Li Edgar Lee | 1 | 1 |
| Xin Edgar Fu | 1 | 1 |
| Yanling Edgar Cao | 1 | 1 |
| Wenjun Edgar Sun | 1 | 1 |
| Cheng Edgar Liu | 1 | 1 |
| Krishna Edgar Viswanadhan | 1 | 1 |
| Yiping James Li | 1 | 1 |
| Harry Edgar Lam | 1 | 1 |
| Jinyin Edgar Wang | 1 | 1 |
| Hans Edgar Bishop | 1 | 1 |
| Xing Edgar Gao | 1 | 1 |
| Yunxia Edgar Yang | 1 | 1 |
| Hongxia Edgar Zheng | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.